<DOC>
	<DOCNO>NCT00432783</DOCNO>
	<brief_summary>Pharmacologic boost protease inhibitor ritonavir become standard practice antiretroviral therapy . Patients instructed take ritonavir time accompany protease inhibitor . However , ritonavir unpopular many patient large size recommend need refrigeration . This study test hypothesis adherence ritonavir inferior adherence accompany protease inhibitor patient receive therapy .</brief_summary>
	<brief_title>A Comparison Adherence Rates Ritonavir Its Accompanying Protease Inhibitor</brief_title>
	<detailed_description>The study staff employ MEMS cap prospectively measure adherence ritonavir accompany protease inhibitor 24 week follow-up . Paired sample t-tests employ compare adherence two agent , secondary analysis conduct evaluate chronologic concordance ritonavir accompany protease inhibitor dosing .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>HIV infection , age &gt; 18 year , receive therapy ritonavirboosted atazanavir fosamprenavir , willingness use MEMS cap , willingness provide inform consent Treatment medication contraindicate combination ritonavir accompany protease inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>HIV , antiretroviral therapy , adherence , ritonavir</keyword>
</DOC>